Scarica l'app Stockscreener
55.80
0.36%
0.20
Dopo l'orario di chiusura:
55.80
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$55.60
Aprire:
$55.56
Volume 24 ore:
350.66K
Relative Volume:
0.97
Capitalizzazione di mercato:
$1.91B
Reddito:
-
Utile/perdita netta:
$-91.00M
Rapporto P/E:
-15.20
EPS:
-3.67
Flusso di cassa netto:
$-74.38M
1 W Prestazione:
-2.87%
1M Prestazione:
-11.99%
6M Prestazione:
+29.29%
1 anno Prestazione:
-15.13%
Intervallo 1D:
$55.30
$57.43
Intervallo di 1 settimana:
$54.24
$59.25
Portata 52W:
$25.60
$77.60
Disc Medicine Inc Stock (IRON) Company Profile
Nome
Disc Medicine Inc
Settore
Industria
Telefono
(617) 674-9274
Indirizzo
321 ARSENAL STREET, SUITE 101, WATERTOWN
Confronta IRON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
55.80 | 1.91B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-05 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-22 | Iniziato | Wells Fargo | Overweight |
| 2024-04-01 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-05-17 | Iniziato | Raymond James | Outperform |
| 2023-04-28 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Iniziato | Stifel | Buy |
| 2023-04-20 | Iniziato | Morgan Stanley | Overweight |
| 2023-03-23 | Iniziato | BMO Capital Markets | Outperform |
| 2023-02-28 | Iniziato | SVB Securities | Outperform |
Mostra tutto
Disc Medicine Inc Borsa (IRON) Ultime notizie
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
WilmerHale Advises Underwriters in Upsized $259.3 Million Follow-on Public Offering of Disc Medicine - WilmerHale
JPMorgan Chase & Co. Purchases 2,257 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
How To Trade (IRON) - Stock Traders Daily
Stifel Nicolaus Increases Disc Medicine (NASDAQ:IRON) Price Target to $94.00 - MarketBeat
Stifel raises Disc Medicine stock target to $94, maintains Buy By Investing.com - Investing.com Canada
Stifel raises Disc Medicine stock target to $94, maintains Buy - Investing.com India
Disc Medicine (NASDAQ:IRON) Sees Large Volume Increase After Analyst Upgrade - MarketBeat
Disc Medicine’s (IRON) Outperform Rating Reiterated at Wedbush - Defense World
Disc Medicine (NASDAQ:IRON) Sees Unusually-High Trading Volume on Analyst Upgrade - Defense World
FY2026 Earnings Estimate for Disc Medicine Issued By Wedbush - MarketBeat
Disc raises $225.5m as it eyes approval of rare skin disorder drug - Yahoo Finance
Disc Medicine announces pricing of $225.5M upsized public offering - MSN
Cantor Fitzgerald Comments on Disc Medicine FY2025 Earnings - Defense World
Wedbush Has Optimistic View of Disc Medicine FY2028 Earnings - Defense World
Disc Medicine Raises $225.5M in Upsized Public Offering to Advance Bitopertin Development - StockTitan
Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire
Disc Medicine (NASDAQ:IRON) Shares Gap DownHere's Why - MarketBeat
Scotiabank Forecasts Strong Price Appreciation for Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Progress Software, Disc Medicine And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
FY2028 Earnings Estimate for Disc Medicine Issued By Wedbush - MarketBeat
Cantor Fitzgerald Estimates Disc Medicine FY2025 Earnings - MarketBeat
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire
Disc Medicine Announces Successful Type C Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria and Shares Plans for NDA Submission - Marketscreener.com
Disc Medicine: Potential Promise Amid Uncertainty (NASDAQ:IRON) - Seeking Alpha
Disc Medicine Announces $200M Public Offering to Advance EPP Treatment Pipeline - StockTitan
Disc Medicine (NASDAQ:IRON) Receives Buy Rating from HC Wainwright - MarketBeat
Wedbush Reaffirms "Outperform" Rating for Disc Medicine (NASDAQ:IRON) - MarketBeat
Disc Medicine Announces Successful Type C Meeting with FDA - GlobeNewswire
Disc Medicine to Host FDA Meeting Update Call on Bitopertin EPP Treatment Progress - StockTitan
Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP) - GlobeNewswire
Disc Medicine, Inc. (NASDAQ:IRON) Short Interest Up 6.6% in December - MarketBeat
Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Exciting News From a Fast-Growing Biopharma! New Employee Benefits Unveiled! - Zaman
Disc Medicine's SWOT analysis: rare blood disorder stock shows promise By Investing.com - Investing.com Australia
Disc Medicine's SWOT analysis: rare blood disorder stock shows promise - Investing.com India
How the (IRON) price action is used to our Advantage - Stock Traders Daily
Wedbush Reiterates Outperform Rating for Disc Medicine (NASDAQ:IRON) - Defense World
Disc Medicine (NASDAQ:IRON) Earns "Outperform" Rating from Wedbush - MarketBeat
Disc Medicine Highlights 2025 Strategy and Financial Updates - TipRanks
Disc Medicine Highlights Recent Achievements Across Hematology Portfolio and Key Business Objectives and Milestones for 2025 - The Manila Times
Disc Medicine Highlights Recent Achievements Across - GlobeNewswire
Disc Medicine Advances EPP Treatment: FDA Fast-Track Talks & $178M Funding Boost Clinical Pipeline - StockTitan
Disc medicine chief legal officer sells $470,657 in stock By Investing.com - Investing.com Australia
Disc Medicine, Inc. (NASDAQ:IRON) Insider Sells $470,625.00 in Stock - MarketBeat
Disc medicine chief legal officer sells $470,657 in stock - Investing.com India
When (IRON) Moves Investors should Listen - Stock Traders Daily
Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
John D. Quisel Sells 13,012 Shares of Disc Medicine, Inc. (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine Inc Azioni (IRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.95%
2.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):